Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Telus Corporation Ordinary Shares (TU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Telus Corporation Ordinary Shares — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Telus Corporation Ordinary Shares trades at $8.11 (market cap $12.52B). The key difference: Telus Corporation Ordinary Shares is the larger of the two by market cap, and Telus Corporation Ordinary Shares pays a 6.59% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Telus Corporation Ordinary Shares for 0 Days on average.
| KYMR | TU | |
|---|---|---|
Market Cap | $8.87B | $12.52B |
Volume | 779,107 | 6,655,034 |
Sector | Health | Media |
52-Week High | $127.31 | $15.33 |
52-Week Low | $55.80 | $7.72 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $33.57B |
Dividend Yield | — | 6.59% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Telus Corporation Ordinary Shares
Telus Corporation is a Canadian telecommunications company providing wireless, internet, television, and business connectivity services, with additional operations in digital healthcare through Telus Health and customer experience services through Telus Digital.
Read more on TU →
